Genetics in Dystonia: An Update

Movement Disorders (SA Factor, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Movement Disorders


The past year has been extremely successful with regard to the genetics of dystonia, with the identification of four new dystonia genes (CIZ1, ANO3, GNAL, and TUBB4A). This progress was primarily achieved because of the application of a new technology, next-generation DNA sequencing, which allows rapid and comprehensive assessment of a patient’s genome. In addition, a combination of next-generation and traditional Sanger sequencing has expanded the phenotypic spectrum associated with some of the dystonia plus (ATP1A3) and paroxysmal (PRRT2) loci. This article reviews the newly identified genes and phenotypes and discusses the future applications of next-generation sequencing to dystonia research.


Dystonia Genetics Next-generation sequencing Exome CIZ1 ANO3 GNAL TUBB4A Phenotypic spectrum 


Papers of particular interest, published recently, have been highlighted as •• Of major importance

  1. 1.
    Fahn S, Bressman SB, Marsden CD. Classification of dystonia. Adv Neurol. 1998;78:1–10.PubMedGoogle Scholar
  2. 2.
    Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28:863–73.PubMedCrossRefGoogle Scholar
  3. 3.
    Defazio G, Berardelli A, Hallett M. Do primary adult-onset focal dystonias share aetiological factors? Brain. 2007;130:1183–93.PubMedCrossRefGoogle Scholar
  4. 4.
    Fuchs T, Ozelius LJ. Genetics of dystonia. Semin Neurol. 2011;31:441–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Ku CS, Cooper DN, Polychronakos C, et al. Exome sequencing: dual role as a discovery and diagnostic tool. Ann Neurol. 2012;71:5–14.PubMedCrossRefGoogle Scholar
  6. 6.
    Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988;3:188–94.PubMedCrossRefGoogle Scholar
  7. 7.
    Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol. 2000;247:787–92.CrossRefGoogle Scholar
  8. 8.
    Risch N, de Leon D, Ozelius L, et al. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet. 1995;9:152–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Muller J, Kiechl S, Wenning GK, et al. The prevalence of primary dystonia in the general community. Neurology. 2002;59:941–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Xiao J, Uitti RJ, Zhao Y, et al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol. 2012;71:458–69.PubMedCrossRefGoogle Scholar
  11. 11.
    •• Charlesworth G, Plagnol V, Holmstrom KM, et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet. 2012;91:1041–50. This article describes a novel dystonia causative gene, ANO3, identified by exome sequencing in familial dystonia. The dystonia phenotype associated with ANO3 mutations comprises mostly a focal or segmental distribution with wide a range of onset (between early childhood and 40 years) All of the mutation carriers had dystonia involving the craniocervical region, but some also had laryngeal dystonia, blepharospasm, and/or limb tremor One mutation-positive patient was previously diagnosed with essential tremor, raising the possibility that mutations in ANO3 may also cause tremor associated with dystonia.PubMedCrossRefGoogle Scholar
  12. 12.
    •• Fuchs T, Saunders-Pullman R, Masuho I, et al. Mutations in GNAL cause primary torsion dystonia. Nat Genet. 2012;45:88–92. This article describes the identification of GNAL by exome sequencing. GNAL mutations were found only in familial cases, and the associated phenotype is characterized by an average age of onset of 31.3 years, mostly focal to segmental distribution with rare generalization, onset in the neck in 82% of carriers, and prominent neck involvement (93% of carriers) at the final examination.PubMedCrossRefGoogle Scholar
  13. 13.
    •• Hersheson J, Mencacci NE, Davis M, et al. Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol. 2013;73:546–53. Exome sequencing identified TUBB4A as a dystonia causative gene for the previously described DYT4 locus. This locus and phenotype were described in a single Australian family with “whispering dysphonia” that progresses to a generalized dystonia with a characteristic “hobby horse” ataxic gait.CrossRefGoogle Scholar
  14. 14.
    •• Lohmann K, Wilcox RA, Winkler S, et al. Whispering dysphonia (DYT4 dystonia) is caused by a mutation in the TUBB4 gene. Ann Neurol. 2013;73:537–45. Exome sequencing identified TUBB4A as a dystonia causative gene for the previously described DYT4 locus. This locus and phenotype were described in a single Australian family with “whispering dysphonia” that progresses to a generalized dystonia with a characteristic “hobby horse” ataxic gait. The mutations in TUBB4A are not expected to be responsible for a significant proportion of dystonia, since screening of the gene in 394 unrelated dystonia patients revealed only one additional putative mutation.CrossRefGoogle Scholar
  15. 15.
    Winter P, Kamm C, Biskup S, et al. DYT7 gene locus for cervical dystonia on chromosome 18p is questionable. Mov Disord. 2012;27:1819–21.PubMedCrossRefGoogle Scholar
  16. 16.
    Uitti RJ, Maraganore DM. Adult onset familial cervical dystonia: report of a family including monozygotic twins. Mov Disord. 1993;8:489–94.PubMedCrossRefGoogle Scholar
  17. 17.
    Arman PR, del Grosso N, Valente EM, et al. Primary torsion dystonia: the search for genes is not over. J Neurol Neurosurg Psychiatry. 1999;67:395–7.CrossRefGoogle Scholar
  18. 18.
    Klein C, Konig IR, Lohmann K. Exome sequencing for gene discovery: time to set standard criteria. Ann Neurol. 2012;72:627–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Mitsui K, Matsumoto A, Ohtsuka S, et al. Cloning and characterization of a novel p21(Cip1/Waf1)-interacting zinc finger protein, ciz1. Biochem Biophys Res Commun. 1999;264:457–64.PubMedCrossRefGoogle Scholar
  20. 20.
    Coverley D, Marr J, Ainscough J. Ciz1 promotes mammalian DNA replication. J Cell Sci. 2005;118:101–12.PubMedCrossRefGoogle Scholar
  21. 21.
    Rahman F, Ainscough JF, Copeland N, Coverley D. Cancer-associated missplicing of exon 4 influences the subnuclear distribution of the DNA replication factor CIZ1. Hum Mutat. 2007;28:993–1004.PubMedCrossRefGoogle Scholar
  22. 22.
    Duran C, Qu Z, Osunkoya AO, et al. ANOs 3–7 in the anoctamin/Tmem16 Cl- channel family are intracellular proteins. Am J Physiol Cell Physiol. 2012;302:C482–93.PubMedCrossRefGoogle Scholar
  23. 23.
    Jones DT, Reed RR. Golf: an olfactory neuron specific-G protein involved in odorant signal transduction. Science. 1989;244:790–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Drinnan SL, Hope BT, Snutch TP, Vincent SR. Golf in the basal ganglia. Mol Cell Neurosci. 1991;2:66–70.PubMedCrossRefGoogle Scholar
  25. 25.
    Kull B, Svenningsson P, Fredholm BB. Adenosine A2A receptors are colocalized with and activate Golf in rat striatum. Mol Pharmacol. 2000;58:771–7.PubMedGoogle Scholar
  26. 26.
    Corvol JC, Studler JM, Schonn JS, et al. Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum. J Neurochem. 2001;76:1585–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Corvol JC, Valjent E, Pascoli V, et al. Quantitative changes in Gαolf protein levels, but not D1 receptor, alter specifically acute responses to psychostimulants. Neuropsychopharmacology. 2007;32:1109–21.PubMedCrossRefGoogle Scholar
  28. 28.
    Belluscio L, Gold GH, Nemes A, Axel R. Mice deficient in Golf are anosmic. Neuron. 1998;20:69–81.PubMedCrossRefGoogle Scholar
  29. 29.
    Alcacer C, Santini E, Valjent E, et al. Gαolf mutation allows parsing the role of cAMP-dependent and extracellular signal-regulated kinase-dependent signaling in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci. 2012;32:5900–10.PubMedCrossRefGoogle Scholar
  30. 30.
    Corvol JC, Muriel MP, Valjent E, et al. Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. J Neurosci. 2004;24:7007–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Berrettini WH, Vuoristo J, Ferraro TN, et al. Human Golf gene polymorphisms and vulnerability to bipolar disorder. Psychiatr Genet. 1998;8(4):235–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Segurado R, Detera-Wadleigh SD, Levinson DF, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: bipolar disorder. Am J Hum Genet. 2003;73:49–62.PubMedCrossRefGoogle Scholar
  33. 33.
    Laurin N, Ickowicz A, Pathare T, et al. Investigation of the G protein subunit Gαolf gene (GNAL) in attention deficit/hyperactivity disorder. J Psychiatr Res. 2008;42:117–24.PubMedCrossRefGoogle Scholar
  34. 34.
    Vemula SR, Puschmann A, Xiao J, et al. Role of Gα(olf) in familial and sporadic adult-onset primary dystonia. Hum Mol Genet. 2013;22:2510–9.PubMedCrossRefGoogle Scholar
  35. 35.
    Parker N. Hereditary whispering dysphonia. J Neurol Neurosurg Psychiatry. 1985;48:218–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Ahmad F, Davis MB, Waddy HM, et al. Evidence for locus heterogeneity in autosomal dominant torsion dystonia. Genomics. 1993;15:9–12.PubMedCrossRefGoogle Scholar
  37. 37.
    Wilcox RA, Winkler S, Lohmann K, Klein C. Whispering dysphonia in an Australian family (DYT4): a clinical and genetic reappraisal. Mov Disord. 2011;26:2404–8.PubMedCrossRefGoogle Scholar
  38. 38.
    Mandelkow E, Mandelkow EM. Microtubules and microtubule-associated proteins. Curr Opin Cell Biol. 1995;7:72–81.PubMedCrossRefGoogle Scholar
  39. 39.
    Yen TJ, Gay DA, Pachter JS, Cleveland DW. Autoregulated changes in stability of polyribosome-bound beta-tubulin mRNAs are specified by the first 13 translated nucleotides. Mol Cell Biol. 1988;8:1224–35.PubMedGoogle Scholar
  40. 40.
    Yen TJ, Machlin PS, Cleveland DW. Autoregulated instability of β-tubulin mRNAs by recognition of the nascent amino terminus of β-tubulin. Nature. 1988;334:580–5.PubMedCrossRefGoogle Scholar
  41. 41.
    Simons C, Wolf NI, McNeil N, et al. A de Novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum. Am J Hum Genet. 2013;92:767–73.PubMedCrossRefGoogle Scholar
  42. 42.
    Leube B, Rudnicki D, Ratzlaff T, et al. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum Mol Genet. 1996;5:1673–7.PubMedCrossRefGoogle Scholar
  43. 43.
    de Carvalho Aguiar P, Sweadner KJ, Penniston JT, et al. Mutations in the Na+/K+-ATPase α3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron. 2004;43:169–75.PubMedCrossRefGoogle Scholar
  44. 44.
    Brashear A, Dobyns WB, de Carvalho Aguiar P, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain. 2007;130:828–35.PubMedCrossRefGoogle Scholar
  45. 45.
    Brashear A, Mink JW, Hill DF, et al. ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia. Dev Med Child Neurol. 2012;54:1065–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Brashear A, Cook JF, Hill DF, et al. Psychiatric disorders in rapid-onset dystonia-parkinsonism. Neurology. 2012;79:1168–73.PubMedCrossRefGoogle Scholar
  47. 47.
    •• Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2012;44:1030–4. This is one of the first articles (along with [48]) to identify mutations in the ATP1A3 gene in patients with AHC. This expands the phenotypic spectrum associated with mutations in this gene beyond the original description of RDP and suggests these disorders are part of the same clinical spectrum.PubMedCrossRefGoogle Scholar
  48. 48.
    •• Rosewich H, Thiele H, Ohlenbusch A, et al. Heterozygous de-novo mutations in ATP1A3 in patients with alternating hemiplegia of childhood: a whole-exome sequencing gene-identification study. Lancet Neurol. 2012;11:764–73. This is one of the first articles (along with [47]) to identify mutations in the ATP1A3 gene in patients with AHC. This expands the phenotypic spectrum associated with mutations in this gene beyond the original description of RDP and suggests these disorders are part of the same clinical spectrum.PubMedCrossRefGoogle Scholar
  49. 49.
    Ishii A, Saito Y, Mitsui J, et al. Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients. PLoS One. 2013;8:e56120.PubMedCrossRefGoogle Scholar
  50. 50.
    Bourgeois M, Aicardi J, Goutieres F. Alternating hemiplegia of childhood. J Pediatr. 1993;122:673–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Ozelius LJ, Lubarr N, Bressman SB. Milestones in dystonia. Mov Disord. 2011;26:1106–26.PubMedCrossRefGoogle Scholar
  52. 52.
    Roubergue A, Roze E, Vuillaumier-Barrot S, et al. The multiple faces of the ATP1A3-related dystonic movement disorder. Mov Disord. 2013;28:1457–9.PubMedGoogle Scholar
  53. 53.
    Ozelius LJ. Clinical spectrum of disease associated with ATP1A3 mutations. Lancet Neurol. 2012;11:741–3.PubMedCrossRefGoogle Scholar
  54. 54.
    Bruno MK, Hallett M, Gwinn-Hardy K, et al. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004;63:2280–7.PubMedCrossRefGoogle Scholar
  55. 55.
    Tomita H, Nagamitsu S, Wakui K, et al. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am J Hum Genet. 1999;65:1688–97.PubMedCrossRefGoogle Scholar
  56. 56.
    Valente EM, Spacey SD, Wali GM, et al. A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain. 2000;123:2040–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Chen WJ, Lin Y, Xiong ZQ, et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat Genet. 2011;43:1252–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Li J, Zhu X, Wang X, et al. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J Med Genet. 2012;49:76–8.PubMedCrossRefGoogle Scholar
  59. 59.
    Wang JL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain. 2011;134:3493–501.PubMedCrossRefGoogle Scholar
  60. 60.
    Lee HY, Huang Y, Bruneau N, et al. Mutations in the novel protein PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep. 2012;1:2–12.CrossRefGoogle Scholar
  61. 61.
    Gardiner AR, Bhatia KP, Stamelou M, et al. PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology. 2012;79:2115–21.PubMedCrossRefGoogle Scholar
  62. 62.
    Meneret A, Grabli D, Depienne C, et al. PRRT2 mutations: a major cause of paroxysmal kinesigenic dyskinesia in the European population. Neurology. 2012;79:170–4.PubMedCrossRefGoogle Scholar
  63. 63.
    Meneret A, Gaudebout C, Riant F, et al. PRRT2 mutations and paroxysmal disorders. Eur J Neurol. 2013;20:872–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Silveira-Moriyama L, Gardiner AR, Meyer E, et al. Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations. Dev Med Child Neurol. 2013;55:327–34.PubMedCrossRefGoogle Scholar
  65. 65.
    Labate A, Tarantino P, Viri M, et al. Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences. Epilepsia. 2012;53:e196–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Genetics and Genomic SciencesIchan School of Medicine at Mount SinaiNew YorkUSA
  2. 2.Department of NeurologyIchan School of Medicine at Mount SinaiNew YorkUSA

Personalised recommendations